Skip to content

Clinical trials

Phase 3 ST Elevation Myocardial Infarction trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: ST Elevation Myocardial Infarction Phase: Phase 3 Country / region: United States Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20072
20131
20141
20161
20181
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated4
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
CeleCor Therapeutics1
Cogentus Pharmaceuticals1
Faraday Pharmaceuticals, Inc.1
GlaxoSmithKline1
Medstar Health Research Institute1
Novartis Pharmaceuticals1
Population Health Research Institute1
Stentys1
The Medicines Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
ST Elevation Myocardial Infarction9
Non-ST Elevated Myocardial Infarction5
Myocardial Infarction4
Acute Coronary Syndrome3
Cardiovascular Diseases1
Cerebrovascular Disorders1
Coronary Artery Disease1
Coronary Thrombosis1
Duodenal Obstruction1
Duodenal Ulcer1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.